In line with their metabolic and transcriptomic profile, CD137HI monocytes displayed a superior phagocytic capacity in terms of bacterial pathogens as well as lymphoma or MM cell lines that were pretreated with anti-CD20 and anti-CD38 mAbs [24]. This evidence concerns the gene CD38 and Miyoshi myopathy.